Back to Search
DAVID SHERRIS, MD
MD
Otolaryngology Physician
NPI: 1689646739Individual
Specialties, Licenses & Credentials
Plastic Surgery — Plastic Surgery Within the Head and Neck
Code: 2082S0099X
178951(NY)
Education
UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY
Class of 1988
Research & Publications (20)
Muller cell reactivity and photoreceptor cell death are reduced after experimental retinal detachment using an inhibitor of the Akt/mTOR pathway.
PMID 19369237·Invest Ophthalmol Vis Sci·2009
7-preclinical
The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer.
PMID 19240717·Br J Cancer·2009
8-other
Palomid 529, a novel small-molecule drug, is a TORC1/TORC2 inhibitor that reduces tumor growth, tumor angiogenesis, and vascular permeability.
PMID 19010932·Cancer Res·2008
7-preclinical
Static procedures for the management of the midface and lower face.
PMID 18470832·Facial Plast Surg·2008
8-other
Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B.
PMID 18360640·Ther Clin Risk Manag·2007
8-other
The use of botulinum toxin A in perioral rejuvenation.
PMID 18005882·Facial Plast Surg Clin North Am·2007
6-review
The role of ubiquitous airborne fungi in chronic rhinosinusitis.
PMID 17534052·Clin Allergy Immunol·2007
6-review
The role of airborne mold in chronic rhinosinusitis.
PMID 16950303·J Allergy Clin Immunol·2006
8-other
Botulinum toxin to improve facial wound healing: A prospective, blinded, placebo-controlled study.
PMID 16901024·Mayo Clin Proc·2006
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1237 DELAWARE AVE
BUFFALO, NY 14209 - Phone
- (716) 884-5102
Quick Facts
- NPI
- 1689646739
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile